UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 347

Sortiert nach

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

Arthritis & rheumatology (Hoboken, N.J.), 2017-07, Vol.69 (7), p.1451-1460

2017

Volltextzugriff (PDF)

Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

Journal of Scleroderma and Related Disorders, 2017-01, Vol.2 (1), p.11-18

2017

Volltextzugriff (PDF)

The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2016-02, Vol.68 (2), p.299-311

2016

Volltextzugriff (PDF)

Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials

Arthritis research & therapy, 2015-12, Vol.17 (372), p.372, Article 372

2015

Volltextzugriff (PDF)

Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

Arthritis research & therapy, 2019-01, Vol.21 (1), p.23-9, Article 23

2019

Volltextzugriff (PDF)

Predictive Significance of Serum Interferon‐Inducible Protein Score for Response to Treatment in Systemic Sclerosis–Related Interstitial Lung Disease

Arthritis & rheumatology (Hoboken, N.J.), 2021-06, Vol.73 (6), p.1005-1013

2021

Volltextzugriff (PDF)

High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung Disease

Chest, 2008-08, Vol.134 (2), p.358-367

2008

Volltextzugriff (PDF)

Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II

ACR open rheumatology, 2020-06, Vol.2 (6), p.362-370

2020

Volltextzugriff (PDF)

Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts

ACR open rheumatology, 2022-05, Vol.4 (5), p.417-425

2022

Volltextzugriff (PDF)

Determining progression of scleroderma-related interstitial lung disease

Journal of scleroderma and related disorders, 2019-02, Vol.4 (1), p.62-70

2019

Volltextzugriff (PDF)

Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrument

Arthritis and rheumatism, 2009-09, Vol.61 (9), p.1257-1263

2009

Volltextzugriff (PDF)

The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

Arthritis care & research (2010), 2016-02, Vol.68 (2), p.167-178

2016

Volltextzugriff (PDF)

Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease

Chest, 2017-04, Vol.151 (4), p.813-820

2017

Volltextzugriff (PDF)

Arthritis in Systemic Sclerosis: Systematic Review of the Literature and Suggestions for the Performance of Future Clinical Trials in Systemic Sclerosis Arthritis

Seminars in arthritis and rheumatism, 2012-06, Vol.41 (6), p.801-814

2012

Volltextzugriff (PDF)

Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial

Journal of rheumatology, 2005-05, Vol.32 (5), p.832

2005

Volltextzugriff (PDF)

Racial Disparities in Systemic Sclerosis: Short‐ and Long‐Term Outcomes Among African American Participants of SLS I and II

ACR open rheumatology, 2021-01, Vol.3 (1), p.8-16

2021

Volltextzugriff (PDF)

Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6

Journal of rheumatology, 2003-07, Vol.30 (7), p.1630

2003

Volltextzugriff (PDF)

Adverse Events during the Scleroderma Lung Study

The American journal of medicine, 2011-05, Vol.124 (5), p.459-467

2011

Volltextzugriff (PDF)

Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study

Arthritis care & research (2010), 2010-12, Vol.62 (12), p.1772-1778

2010

Volltextzugriff (PDF)

Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap

Chest, 2013-02, Vol.143 (2), p.324-332

2013

Volltextzugriff (PDF)

Reliability, Validity, and Minimally Important Differences of the SF-6D in Systemic Sclerosis

Quality of life research, 2007-08, Vol.16 (6), p.1083-1092

2007

Volltextzugriff (PDF)

Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis

Journal of rheumatology, 2007-02, Vol.34 (2), p.359

2007

Volltextzugriff (PDF)

Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium

Arthritis & rheumatology (Hoboken, N.J.), 2016-06, Vol.68 (6), p.1483-1492

2016

Volltextzugriff (PDF)

An interim report of the Scleroderma Clinical Trials Consortium working groups

Journal of Scleroderma and Related Disorders, 2019-02, Vol.4 (1), p.17-27

2019

Volltextzugriff (PDF)

1 – 25 von 347

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(291)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(234)
Life Sciences & Biomedicine
(211)
Humans
(203)
Female
(130)
Male
(122)
Middle Aged
(101)
Rheumatology
(100)
Biological And Medical Sciences
(97)
Medical Sciences
(92)
Adult
(90)
Scleroderma, Systemic - Complications
(54)
Scleroderma
(53)
Systemic Sclerosis
(50)
Aged
(48)
Treatment Outcome
(40)
Scleroderma, Systemic - Drug Therapy
(38)
Scleroderma, Systemic - Physiopathology
(37)
Diseases Of The Osteoarticular System
(30)
General & Internal Medicine
(29)
Double-Blind Method
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials

Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

Predictive Significance of Serum Interferon‐Inducible Protein Score for Response to Treatment in Systemic Sclerosis–Related Interstitial Lung Disease

High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung Disease

Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II

Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts

Determining progression of scleroderma-related interstitial lung disease

Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrument

The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease

Arthritis in Systemic Sclerosis: Systematic Review of the Literature and Suggestions for the Performance of Future Clinical Trials in Systemic Sclerosis Arthritis

Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial

Racial Disparities in Systemic Sclerosis: Short‐ and Long‐Term Outcomes Among African American Participants of SLS I and II

Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6

Adverse Events during the Scleroderma Lung Study

Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study

Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap

Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)

Reliability, Validity, and Minimally Important Differences of the SF-6D in Systemic Sclerosis

Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis

Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium

An interim report of the Scleroderma Clinical Trials Consortium working groups

Suchergebnisse filtern